The Effects of Time Lag and Cure Rate on the Global Dynamics of HIV-1 Model

In this research article, a new mathematical model of delayed differential equations is developed which discusses the interaction among CD4 T cells, human immunodeficiency virus (HIV), and recombinant virus with cure rate. The model has two distributed intracellular delays. These delays denote the time needed for the infection of a cell. The dynamics of the model are completely described by the basic reproduction numbers represented by R0, R1, and R2. It is shown that if R0 < 1, then the infection-free equilibrium is locally as well as globally stable. Similarly, it is proved that the recombinant absent equilibrium is locally as well as globally asymptotically stable if 1 < R0 < R1. Finally, numerical simulations are presented to illustrate our theoretical results. Our obtained results show that intracellular delay and cure rate have a positive role in the reduction of infected cells and the increasing of uninfected cells due to which the infection is reduced.

[1]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[2]  G. García-Ramos,et al.  Fighting a virus with a virus: a dynamic model for HIV-1 therapy. , 2003, Mathematical biosciences.

[3]  G P Nolan,et al.  Harnessing Viral Devices as Pharmaceuticals: Fighting HIV-1's Fire with Fire , 1997, Cell.

[4]  A. Perelson,et al.  Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.

[5]  G. Webb,et al.  A mathematical model of cell-to-cell spread of HIV-1 that includes a time delay , 2003, Journal of mathematical biology.

[6]  B. Buonomo,et al.  Global stability for an HIV-1 infection model including an eclipse stage of infected cells , 2011, Journal of Mathematical Analysis and Applications.

[7]  Libin Rong,et al.  Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility. , 2007, Journal of theoretical biology.

[8]  K. Hattaf,et al.  Two optimal treatments of HIV infection model , 2010 .

[9]  J. Zack,et al.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle , 1992, Journal of virology.

[10]  M A Nowak,et al.  Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[12]  Pei Yu,et al.  Impact of delay on HIV-1 dynamics of fighting a virus with another virus. , 2014, Mathematical biosciences and engineering : MBE.

[13]  Pei Yu,et al.  Dynamics of an HIV-1 therapy model of fighting a virus with another virus , 2009, Journal of biological dynamics.

[14]  G. Zaman,et al.  Stability analysis of HIV-1 model with multiple delays , 2016 .

[15]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[16]  J. Rose,et al.  Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection , 1997, Cell.

[17]  Xianning Liu,et al.  Global dynamics of a virus dynamical model with general incidence rate and cure rate , 2014 .

[18]  A S Perelson,et al.  Improved estimates for HIV-1 clearance rate and intracellular delay. , 1999, AIDS.

[19]  N. Yousfi,et al.  A Delay Differential Equation Model of HIV Infection, with Therapy and CTL Response , 2014 .

[20]  Pei Yu,et al.  Bifurcation Analysis on an HIV-1 Model with Constant Injection of recombinant , 2012, Int. J. Bifurc. Chaos.

[21]  Gisela Garc.  Fighting a virus with a virus: a dynamic model for HIV-1 therapy , 2003 .